- 英文名称
- Atorvastatin calcium
- 分子式
- C66H68CaF2N4O10
- 分子量
- 1155.34
- 中文别名
- 7-[2-(4-氟苯基)-3-苯基-4-(苯胺基甲酰基)-5-(2-丙基)吡咯-1-基]-3,5-二羟基庚酸钙; [R,(R*,R*)]-2-(4-氟苯基)-β,α-二羟基-5-(1-甲基乙基)-3-苯基-[(苯胺基)-羟基]-1H-吡咯-1-庚酸钙盐; [R,(R*,R*)]-2-(4-氟苯基)-β,α-二羟基-5-(1-甲基乙基)-3-苯基-[(苯胺基)-羟基]-1H-吡咯-1-庚酸钙盐(2:1); [R,(R*,R*)]-2-(4-氟苯基)-β,α-二羟基-5-(1-甲基乙基)-3-苯基-[(苯胺基)-羟基]-1H-吡咯-1-庚酸钙盐(2:1)三水(结晶型); [R,(R*,R*)]-2-(4-氟苯基)-β,α-二羟基-5-(1-甲基乙基)-3-苯基-[(苯胺基)-羟基]-1H-吡咯-1-庚酸钙盐(无定型); 阿托伐他汀钙晶型Ⅷ; 阿托伐他汀钙晶型I; 阿托伐他汀钙无定型; Atorvastatin calcium salt trihydrate; ATORVASTATIN CALCIUM SALT; ATORVASTATIN CA; [r-(r*, r*)]-7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylaminocarbonyl)-1h-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid calcium salt; (3R,5R)-7-(2-(4-FLUOROPHENYL)-5-ISOPROPYL-3-PHENYL-4-(PHENYLCARBAMOYL)-1H-PYRROL-1-YL)-3,5-DIHYDROXYHEPTANOIC ACID CALCIUM; (R,dR)-2-(4-Fluorophenyl)-,d-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid Calcium; 3S,5S-Atorvastatin Calcium; Lipitor; Calcium (bR,dR)-2-(p-fluorophenyl)-b,d-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoate; calcium bis{(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate}; Liprimar; Lipibec; Atorvastatin hemicalcium salt; calcium bis{(3R,5R)-7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate}
- 用途
- 生命科学；医药，降血脂药，能抑制HMG-CoA还原酶的活性，从而使胆固醇合成减少。
